News in brief: Filippis exits Neurotech; Elixinol completes US sale by Adam Sheldon September 8, 2026September 8, 2026 Neurotech International chief executive and managing director Dr Anthony Filippis has resigned after 19 months in […]
Argent BioPharma halves losses but faces funding ‘uncertainty’ by Adam Sheldon September 1, 2026September 3, 2026
Financial news in brief: Elixinol record quarter; Avecho identifies new trial sites by Steve Jones July 29, 2026July 30, 2026
Argent shares soar after CannEpil deal wipes out US$5.5m debt by Adam Sheldon July 7, 2026July 7, 2026
Financial news in brief: Avecho CBD trial latest; Argent’s milestone delivery; Neurotech reassures ASX by Steve Jones April 29, 2026June 8, 2026
News in brief: 150 applications for council CEO role; Rua sends NZ genetics to Canada; Argent completes pet business deal by Steve Jones April 15, 2026April 15, 2026
Financial news in brief: Avecho; InhaleRx; Neurotech; Peak; Zelira; Argent by Adam Sheldon February 2, 2026June 8, 2026
Argent inks binding agreement to buy AusCann’s CannPal stake by Adam Sheldon January 15, 2026January 15, 2026
Argent BioPharma secures A$11m facility to complete AusCann acquisition by Adam Sheldon November 17, 2025February 21, 2026
Argent BioPharma inks deal to acquire AusCann assets and IP by Martin Lane August 19, 2025August 21, 2025
